Pharmacokinetics of isradipine in participants with parkinson's disease from the phase 3 steady-PD clinical trial

Category Primary study
ConferenceMovement Disorders Clinical Practice
Year 2020
This article has no abstract
Epistemonikos ID: 5634511387f4e13c2e9b5f9a384b5eb5d5ca75c4
First added on: Apr 30, 2026